UCL is is a world-class environment in medical imaging and hosts several medical and biomedical imaging Centres of Excellence in their own right, all part of the newly formed ImagingSciences@UCL, a forum for cross faculty cooperation and interdisciplinary research in medical and biomedical imaging at UCL.
There has been a sustained history of research investment in medical imaging at UCL, including the creation of major centres, such as the Wellcome Trust Centre for Neuroimaging (WTCN), the Centre for Medical Image Computing (CMIC) and the Centre for Advanced Biomedical Imaging (CABI). Major investments have been made to create state-of-the-art facilities such as UK’s first simultaneous PET-MRI system at UCLH (over £5M), the Proton Therapy Centre (over £20M), the Lord Wolfson Experimental Neurology Centre (£36M incl. £16M from UCL). UCL is also investing over £15M in surgery and interventional sciences and has attracted in the last two years over £24M in image guidance for surgery, interventions and cancer imaging.
Our methodological research portfolio is focussed around six major themes, covering the development of the imaging instruments, image acquisition, reconstruction, analysis and computational modeling, and the creation of complex systems combining hardware and software for image-guided surgery and therapy. The six themes are:
- Imaging devices
- Image Acquisition
- Image Reconstruction
- Image Analysis
- Computational Modelling
- Interventional systems
Strategic alliances with UCL Biomedical Research Centres
The CDT is integrated professionally and managerially with elements of the three NIHR Biomedical Research Centres (BRCs) and the Biomedical Research Unit (BRU) in dementia associated with UCL. Uniquely in the UK, UCL is host to three major NIHR BRCs. One is associated with UCLH while the other two are associated with the specialist Moorfields Eye Hospital and Great Ormond Street Children’s Hospital. All undertake internationally competitive experimental medicine (diagnostics and first-into man therapeutics) and a major component of each comprises biomedical imaging in humans. By aligning our CDT with these NIHR BRCs and this BRU and using the dual supervisory system to partner clinical and non-clinical supervisors, we ensure a direct connection between the CDT and clinically relevant projects and environments. This will enhance our ability to deliver transformational training to a generation literate in both imaging science and clinical translation.
The unique partnership with BRCs and BRU provides access to a coherent clinical research portfolio to which our CDT students can deliver on. This clinical research portfolio, engaging the large pool of clinical supervisors available at the BRCs and BRU will be focussed around four major clinical research programmes. These themes represent active clinical research areas where our BRCs and BRU are active in experimental medicine. Our four clinical research programmes are:
Page last modified on 03 dec 13 16:21